Pages that link to "Q52053210"
Jump to navigation
Jump to search
The following pages link to Neuropsychological detection and characterization of preclinical Alzheimer's disease. (Q52053210):
Displaying 50 items.
- Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease (Q22251334) (← links)
- Genetic control of adult neurogenesis: interplay of differentiation, proliferation and survival modulates new neurons function, and memory circuits (Q24628326) (← links)
- Retromer deficiency observed in Alzheimer's disease causes hippocampal dysfunction, neurodegeneration, and Abeta accumulation (Q24654821) (← links)
- Validity of a novel computerized cognitive battery for mild cognitive impairment (Q24792850) (← links)
- Very early changes in olfactory functioning due to Alzheimer's disease and the role of apolipoprotein E in olfaction (Q28296129) (← links)
- APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD). (Q30455082) (← links)
- Imaging Alzheimer's disease (Q30817949) (← links)
- Magnetic resonance imaging of Alzheimer's disease (Q31049661) (← links)
- Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease (Q31111440) (← links)
- Technology Insight: imaging amyloid plaques in the living brain with positron emission tomography and MRI. (Q33255236) (← links)
- Pinpointing synaptic loss caused by Alzheimer's disease with fMRI (Q33511727) (← links)
- Age related cognitive decline: a clinical entity? A longitudinal study of cerebral blood flow and memory performance (Q33735852) (← links)
- Cognitive impairment in elderly who are not yet demented (Q33751407) (← links)
- The prediction and prevention of Alzheimer's disease--towards a research agenda (Q33787542) (← links)
- Increased functional brain response during word retrieval in cognitively intact older adults at genetic risk for Alzheimer's disease (Q33823353) (← links)
- The brain in the age of old: the hippocampal formation is targeted differentially by diseases of late life. (Q33839388) (← links)
- Lexical retrieval in discourse: an early indicator of Alzheimer's dementia (Q33893311) (← links)
- The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment (Q33899078) (← links)
- Neuropsychological contributions to the early identification of Alzheimer's disease (Q33899973) (← links)
- Changes in cognition. (Q34073106) (← links)
- Aging, mild cognitive impairment, and Alzheimer's disease (Q34079583) (← links)
- Estimating and disclosing the risk of developing Alzheimer‘s disease: challenges, controversies and future directions (Q34135724) (← links)
- Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease (Q34509732) (← links)
- Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 2 (Q34551727) (← links)
- Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease (Q34570703) (← links)
- Cognitive discrepancies versus APOE genotype as predictors of cognitive decline in normal-functioning elderly individuals: a longitudinal study (Q34632311) (← links)
- The fate of the 0.5s: predictors of 2-year outcome in mild cognitive impairment (Q34807653) (← links)
- Neuroinflammation and anti-inflammatory therapy for Alzheimer's disease (Q35009772) (← links)
- Self-administered screening for mild cognitive impairment: initial validation of a computerized test battery (Q35017028) (← links)
- Decline in verbal memory during preclinical Alzheimer's disease: examination of the effect of APOE genotype (Q35107333) (← links)
- Assessing the discriminant ability, reliability, and comparability of multiple short forms of the Boston Naming Test in an Alzheimer's disease center cohort (Q35219395) (← links)
- Mild cognitive impairment: historical development and summary of research (Q35236843) (← links)
- Long term effects of early adversity on cognitive function. (Q35277167) (← links)
- Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful. (Q35472824) (← links)
- Mild cognitive impairment: a cross-national comparison (Q35483148) (← links)
- Brain aging, Alzheimer's disease, and mitochondria (Q35533354) (← links)
- Depression is associated with cognitive dysfunction in older adults with heart failure (Q35614944) (← links)
- Aberrant functional connectivity in Papez circuit correlates with memory performance in cognitively intact middle-aged APOE4 carriers (Q35664370) (← links)
- Combining brain imaging with microarray: isolating molecules underlying the physiologic disorders of the brain (Q35791549) (← links)
- The neuropsychological profile of Alzheimer disease (Q35852983) (← links)
- Glycemia, Diabetes Status, and Cognition in Hispanic Adults Aged 55-64 Years (Q35854991) (← links)
- Neuropsychological tests for predicting cognitive decline in older adults (Q35878768) (← links)
- Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance (Q35894767) (← links)
- Children of persons with Alzheimer disease: what does the future hold? (Q36039851) (← links)
- δ-Catenin is genetically and biologically associated with cortical cataract and future Alzheimer-related structural and functional brain changes (Q36227117) (← links)
- Neuropsychological prediction of dementia in Parkinson's disease (Q36317822) (← links)
- Neurologic and motor dysfunctions in APP transgenic mice (Q36347389) (← links)
- Is the Alzheimer's disease cortical thickness signature a biological marker for memory? (Q36348325) (← links)
- Predictors of Retest Effects in a Longitudinal Study of Cognitive Aging in a Diverse Community-Based Sample (Q36664794) (← links)
- Age-related changes in memory and fluid reasoning in a sample of healthy old people (Q36758572) (← links)